Evidence map›Paper›PMID 34685492›Full record

ReviewCells2021

Muscle Regeneration and RNA: New Perspectives for Ancient Molecules.

Giulia Buonaiuto, Fabio Desideri, Valeria Taliani, Monica Ballarino

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giulia BuonaiutoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-4099-2433
Fabio DesideriDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.
Valeria TalianiDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.
Monica BallarinoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-8595-7105
Sapienza University of Rome · IT

Funding

Regione Lazio 2020-T0002E0001Sapienza University RM11916B7A39DCE5Sapienza University RM120172B7D32C04
6 · The paper itself

Abstract

The ability of the ribonucleic acid (RNA) to self-replicate, combined with a unique cocktail of chemical properties, suggested the existence of an RNA world at the origin of life. Nowadays, this hypothesis is supported by innovative high-throughput and biochemical approaches, which definitively revealed the essential contribution of RNA-mediated mechanisms to the regulation of fundamental processes of life. With the recent development of SARS-CoV-2 mRNA-based vaccines, the potential of RNA as a therapeutic tool has received public attention. Due to its intrinsic single-stranded nature and the ease with which it is synthesized in vitro, RNA indeed represents the most suitable tool for the development of drugs encompassing every type of human pathology. The maximum effectiveness and biochemical versatility is achieved in the guise of non-coding RNAs (ncRNAs), which are emerging as multifaceted regulators of tissue specification and homeostasis. Here, we report examples of coding and ncRNAs involved in muscle regeneration and discuss their potential as therapeutic tools. Small ncRNAs, such as miRNA and siRNA, have been successfully applied in the treatment of several diseases. The use of longer molecules, such as lncRNA and circRNA, is less advanced. However, based on the peculiar properties discussed below, they represent an innovative pool of RNA biomarkers and possible targets of clinical value.

Indexed as

RegenerationAnimalsBiomarkersCOVID-19HomeostasisHumansMiceMicroRNAsMuscle, SkeletalMyocardiumOrigin of LifeRNA, CircularRNA, Long NoncodingRNA, MessengerRNA, Small InterferingRNA, Small UntranslatedBiomarkersMicroRNAsRNA, CircularRNA, Long NoncodingRNA, MessengerRNA, Small InterferingRNA, Small UntranslatedRNA, UntranslatedRNA, Viralcardiac regenerationnoncoding RNAs (ncRNAs)RNA therapeuticsskeletal muscle regeneration

Identifiers

PMID34685492
PMCPMC8533951
OpenAlexW3199104087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.